The probability of freedom from recurrence 5 years after surgical excision was higher than with a noninvasive approach in patients with nodular basal cell carcinoma, although the analysis did not show ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in ...